TECX
Price:
$30.02
Market Cap:
$566.45M
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator ...[Read more]
Industry
Biotechnology
IPO Date
2018-06-21
Stock Exchange
NASDAQ
Ticker
TECX
According to Tectonic Therapeutic, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.51. This represents a change of -25.87% compared to the average of 24.97 of the last 4 quarters.
The mean historical Current Ratio of Tectonic Therapeutic, Inc. over the last ten years is 10.25. The current 18.51 Current Ratio has changed 17.97% with respect to the historical average. Over the past ten years (40 quarters), TECX's Current Ratio was at its highest in in the September 2025 quarter at 29.15. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
10.25
Median
9.61
Minimum
0.76
Maximum
26.63
Discovering the peaks and valleys of Tectonic Therapeutic, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.57%
Maximum Annual Current Ratio = 26.63
Minimum Annual Increase = -84.02%
Minimum Annual Current Ratio = 0.76
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 26.63 | 110.49% |
| 2024 | 12.65 | 1.57% |
| 2023 | 0.76 | -84.02% |
| 2022 | 4.73 | -32.01% |
| 2021 | 6.95 | -56.78% |
| 2020 | 16.09 | 15.21% |
| 2019 | 13.96 | 13.89% |
| 2018 | 12.26 | 410.15% |
| 2017 | 2.40 | -60.17% |
The current Current Ratio of Tectonic Therapeutic, Inc. (TECX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
13.34
5-year avg
10.34
10-year avg
10.25
Tectonic Therapeutic, Inc.’s Current Ratio is less than Alto Neuroscience, Inc. (20.52), greater than Larimar Therapeutics, Inc. (4.29), greater than Cellectis S.A. (1.52), greater than Lyell Immunopharma, Inc. (7.23), greater than Amarin Corporation plc (3.48), greater than AC Immune S.A. (0.87), greater than DBV Technologies S.A. (4.76), greater than Alpha Tau Medical Ltd. (7.79), greater than Silence Therapeutics plc (9.83), greater than Aldeyra Therapeutics, Inc. (2.72),
| Company | Current Ratio | Market cap |
|---|---|---|
| 20.52 | $798.04M | |
| 4.29 | $311.50M | |
| 1.52 | $299.24M | |
| 7.23 | $297.28M | |
| 3.48 | $331.54M | |
| 0.87 | $244.26M | |
| 4.76 | $371.50M | |
| 7.79 | $883.39M | |
| 9.83 | $327.33M | |
| 2.72 | $118.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tectonic Therapeutic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tectonic Therapeutic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tectonic Therapeutic, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tectonic Therapeutic, Inc. (TECX)?
What is the highest Current Ratio for Tectonic Therapeutic, Inc. (TECX)?
What is the 3-year average Current Ratio for Tectonic Therapeutic, Inc. (TECX)?
What is the 5-year average Current Ratio for Tectonic Therapeutic, Inc. (TECX)?
How does the current Current Ratio for Tectonic Therapeutic, Inc. (TECX) compare to its historical average?